Differential activation of dopaminergic systems in rat brain basal ganglia by morphine and methamphetamine.
Level 5 - mechanism / opinion, no new human data
Level 5 because this is an animal laboratory study in rats.
PubMed 26820597 · doi:10.1016/j.neuroscience.2016.01.043
What was done
Neurochemical and behavioral techniques were used in rats to examine neurotransmitter responses after administration of methamphetamine (2 mg/kg) or morphine (10 mg/kg), focusing on dopamine and GABA release across the striatum, nucleus accumbens, and ventral tegmental area.
What was found
The abstract reports no numerical values, variances, or effect sizes beyond drug dosages. Methamphetamine (2 mg/kg) increased dopamine release from the striatum more potently than from the nucleus accumbens. Morphine (10 mg/kg) produced a significant increase in dopamine release in the nucleus accumbens, but not the striatum, accompanied by decreased GABA release in the ventral tegmental area.
Why it matters
The study shows that morphine and methamphetamine activate distinct regional dopaminergic and GABAergic pathways within the basal ganglia despite both having high abuse liability.
Limits
The investigation was conducted exclusively in rats, limiting direct translation to human pharmacology. The abstract does not disclose sample sizes, specific behavioral metrics, baseline measures, time courses, or quantitative statistical values.
Cited by
- context Methamphetamine administration causes a thousandfold increase in dopamine release.